Company page

Neurogene Inc.

Neurogene Inc. is a public biotechnology company traded under the ticker NGNE on the American market. The company focuses on developing innovative gene therapies for rare neurological diseases. With a market capitalization of approximately $498.2 million, Neurogene aims to address unmet medical needs through its advanced research and development efforts.